Opioid Spotlight: Trump Announces Plans For More Spending As Congress Introduces Two Dozen Bills
Executive Summary
Administration also plans to roll out slate of proposals to decrease drug prices and bring discounts to patients.
You may also be interested in...
Pacira’s Exparel Will Get Separate Medicare Payment; CMS Still Wants Better Opioid-Sparing Data
US Centers for Medicare and Medicaid Services proposes a change to its reimbursement policies for non-opioid pain therapies which will benefit a single product: Pacira’s Exparel. However, the broader message for that company is mixed.
Opioid Use Disorder: Is Reduced Usage A Better Endpoint Than Abstinence?
Some at patient-focused drug development meeting argue that cutting opioid use should not be considered treatment failure and that medications allowing controlled opioid use may be beneficial.
New US FDA Powers On Rx Abuse Could Be 'Tailored' By Congress, Gottlieb Suggests
At House hearing on opioid epidemic, FDA Commissioner responds to range of legislative proposals, including those aimed at agency's drug approval and safety monitoring activities.